Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elismetrep in the Acute Treatment of Migraine
NCT07645924Phase 3Recruiting
- Sponsor
- TriGemX Bio
- Start
- Jul 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 3 trial of elismetrep in migraine, sponsored by TriGemX Bio. Started Jul 2026; status: recruiting.
02
Drugs
elismetrep
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07645924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645924.